MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
102 hedge funds and large institutions have $268M invested in Merrimack Pharmaceuticals, Inc. in 2014 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% less capital invested
Capital invested by funds: $272M → $268M (-$4.32M)
Holders
102
Holding in Top 10
1
Calls
$7.52M
Puts
$2.71M
Top Buyers
| 1 | +$16M | |
| 2 | +$3.62M | |
| 3 | +$1.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.47M |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$1.09M |
Top Sellers
| 1 | -$4.29M | |
| 2 | -$3.82M | |
| 3 | -$3.51M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.1M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.8M |